Antimicrobial pharmacokinetics in pediatric patients on kidney replacement therapy: a comprehensive narrative review
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Pediatric patients on dialysis need adjusted antimicrobial doses due to altered pharmacokinetics (PK). More research is crucial for safe and effective antimicrobial drug dosing in children undergoing kidney replacement therapy (KRT).
Area Of Science
- Pharmacology
- Nephrology
- Pediatrics
Background
- Patients on dialysis often require antimicrobial therapy, particularly for sepsis.
- Altered pharmacokinetics (PK) in dialysis patients necessitate antimicrobial dose adjustments, as established in adult studies.
- Existing pediatric studies on antimicrobial PK during kidney replacement therapy (KRT) are limited, leading to reliance on extrapolated adult data.
Purpose Of The Study
- To review existing literature on antimicrobial PK in pediatric patients undergoing dialysis.
- To identify knowledge gaps in pediatric antimicrobial dosing for patients on KRT.
- To guide future research priorities in this vulnerable population.
Main Methods
- A comprehensive literature review was performed.
- Searched for original studies evaluating antimicrobial PK in pediatric patients on hemodialysis, peritoneal dialysis, or continuous KRT.
- Synthesized findings to describe current knowledge and identify research needs.
Main Results
- Identified 56 original studies on the PK of twelve different antimicrobials in pediatric dialysis patients.
- Demonstrated a significant under-study of antimicrobial PK in pediatric patients on dialysis.
- Highlighted the reliance on adult data for pediatric dosing recommendations.
Conclusions
- Antimicrobial PK in pediatric patients on dialysis is an understudied area.
- This population is at high risk for infections and drug toxicity.
- Future research should prioritize commonly used antimicrobials and those with known toxicity risks at higher concentrations.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...